| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4129224
[patent_doc_number] => 06033902
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Vector comprising a replication competent HIV-1 provirus and a heterologous gene'
[patent_app_type] => 1
[patent_app_number] => 7/987572
[patent_app_country] => US
[patent_app_date] => 1992-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6751
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/033/06033902.pdf
[firstpage_image] =>[orig_patent_app_number] => 987572
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/987572 | Vector comprising a replication competent HIV-1 provirus and a heterologous gene | Dec 7, 1992 | Issued |
Array
(
[id] => 3120385
[patent_doc_number] => 05380830
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-10
[patent_title] => 'Molecular clones of bovine immunodeficiency-like virus'
[patent_app_type] => 1
[patent_app_number] => 7/980324
[patent_app_country] => US
[patent_app_date] => 1992-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 40
[patent_no_of_words] => 11887
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/380/05380830.pdf
[firstpage_image] =>[orig_patent_app_number] => 980324
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/980324 | Molecular clones of bovine immunodeficiency-like virus | Nov 23, 1992 | Issued |
| 07/979975 | GP41 MUTANTS AND THEIR USE AS HIV THERAPEUTICS | Nov 22, 1992 | Abandoned |
Array
(
[id] => 3840917
[patent_doc_number] => 05707864
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Nucleic acids encoding mutated human immunodeficiency virus matrix proteins'
[patent_app_type] => 1
[patent_app_number] => 7/979966
[patent_app_country] => US
[patent_app_date] => 1992-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 9362
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/707/05707864.pdf
[firstpage_image] =>[orig_patent_app_number] => 979966
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/979966 | Nucleic acids encoding mutated human immunodeficiency virus matrix proteins | Nov 22, 1992 | Issued |
Array
(
[id] => 3447374
[patent_doc_number] => 05424197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-13
[patent_title] => 'H. saimiri-HTLV-X region vector'
[patent_app_type] => 1
[patent_app_number] => 7/976661
[patent_app_country] => US
[patent_app_date] => 1992-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7292
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/424/05424197.pdf
[firstpage_image] =>[orig_patent_app_number] => 976661
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/976661 | H. saimiri-HTLV-X region vector | Nov 15, 1992 | Issued |
| 07/953060 | CLONED DNA SEQUENCES RELATED TO THE GENOMIC RNA OF LYMPHADENOPATHY-ASSOCIATED-VIRUS (LAV) AND PROTEINS ENCODED BY SAID LAV GENOMIC RNA | Nov 4, 1992 | Abandoned |
Array
(
[id] => 3584357
[patent_doc_number] => 05549884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Rat or mouse exhibiting behaviors associated with human schizophrenia'
[patent_app_type] => 1
[patent_app_number] => 7/967367
[patent_app_country] => US
[patent_app_date] => 1992-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5656
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/549/05549884.pdf
[firstpage_image] =>[orig_patent_app_number] => 967367
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/967367 | Rat or mouse exhibiting behaviors associated with human schizophrenia | Oct 27, 1992 | Issued |
| 07/965084 | RECOMBINANT RETROVIRUSES | Oct 21, 1992 | Abandoned |
Array
(
[id] => 3982113
[patent_doc_number] => 05861290
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders'
[patent_app_type] => 1
[patent_app_number] => 7/965039
[patent_app_country] => US
[patent_app_date] => 1992-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11933
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861290.pdf
[firstpage_image] =>[orig_patent_app_number] => 965039
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/965039 | Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders | Oct 21, 1992 | Issued |
| 07/936849 | DEFECTIVE, INTERFERING HIV PARTICLES | Aug 27, 1992 | Abandoned |
Array
(
[id] => 3032027
[patent_doc_number] => 05328835
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-07-12
[patent_title] => 'Expression of immunologically reactive HIV envelope proteins'
[patent_app_type] => 1
[patent_app_number] => 7/933980
[patent_app_country] => US
[patent_app_date] => 1992-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6522
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/328/05328835.pdf
[firstpage_image] =>[orig_patent_app_number] => 933980
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/933980 | Expression of immunologically reactive HIV envelope proteins | Aug 23, 1992 | Issued |
| 07/934310 | DOUBLE COPY RETROVIRAL VECTOR | Aug 23, 1992 | Abandoned |
Array
(
[id] => 3811139
[patent_doc_number] => 05770210
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Recombinant vaccinia virus expressing human retrovirus gene'
[patent_app_type] => 1
[patent_app_number] => 7/919384
[patent_app_country] => US
[patent_app_date] => 1992-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 3171
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770210.pdf
[firstpage_image] =>[orig_patent_app_number] => 919384
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/919384 | Recombinant vaccinia virus expressing human retrovirus gene | Jul 28, 1992 | Issued |
| 07/887410 | RETROVIRAL PACKAGING CELL LINES AND PROCESSES OF USING SAME | May 19, 1992 | Abandoned |
Array
(
[id] => 3085416
[patent_doc_number] => 05278056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-01-11
[patent_title] => 'Retroviral packaging cell lines and process of using same'
[patent_app_type] => 1
[patent_app_number] => 7/877269
[patent_app_country] => US
[patent_app_date] => 1992-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5959
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/278/05278056.pdf
[firstpage_image] =>[orig_patent_app_number] => 877269
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/877269 | Retroviral packaging cell lines and process of using same | Apr 28, 1992 | Issued |
| 07/869047 | RECOMBINANT RETROVIRUSES WITH AMPHOTROPIC AND ECOTROPIC HOST RANGES | Apr 13, 1992 | Abandoned |
| 07/859346 | NON-INFECTIOUS HIV PARTICLES AND USES THEREFOR | Mar 26, 1992 | Abandoned |
| 07/847854 | CIS-ACTING REPRESSION SEQUENCES, CIS-ACTING ANTIREPRESSION SEQUENCES, VECTORS, METHODS OF PREPARATION AND USE | Mar 8, 1992 | Abandoned |
Array
(
[id] => 3090414
[patent_doc_number] => 05312737
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-17
[patent_title] => 'CKS method of HCV protein synthesis'
[patent_app_type] => 1
[patent_app_number] => 7/835878
[patent_app_country] => US
[patent_app_date] => 1992-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 8356
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/312/05312737.pdf
[firstpage_image] =>[orig_patent_app_number] => 835878
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/835878 | CKS method of HCV protein synthesis | Feb 13, 1992 | Issued |
| 07/832603 | MOLECULAR CLONING OF THE HIV VIRUS FROM IMMORTALIZED CELL LINES | Feb 11, 1992 | Abandoned |